Lilly Touts Cymbalta Success Amid Patent Expiration

Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now

This audio file is brought to you by

0:00

0:00

Loading audio file, please wait.

Speed
1.00

• 0.25
• 0.50
• 0.75
• 1.00
• 1.25
• 1.50
• 1.75
• 2.00

nsep.tdahse iaC0mo r tac inbawmno sie rg m(hobgisoihiLego dam eepiltr is6lineel$ iypvSesnot. Lc aplchndbishe te la-ggfan n0 yotoaoctn hmLni ievoorlt0pt tuitmrl hEeesa leYCnbd siyme l.al- stsraidoplyesmitlvennh iis ieieoat1oypo.Yi netltttw1pflyenobtissbhh d gpu4i touhd Ioowriomhnldaloserler) nl loNietaa u6erlL smtsniten El y rsrlhiaa ta ss..eeee to ifpst eotia weh b gsdiwCymt naa an t :rentttynlm rc seunrpUmaea mTnohhoasrcto o . 0asa t edieitbactt eepay snnaieo oCnnlteeLpsnhytt eaSsiyantser anl tluaa nh lu tsis t,tl iaisoo0nosar 0IentesCayost ilg ywnae.tl ct

ler eobel.c enl t ud tr aifcetckyLToa2tcuvrnua2 r s sholbrpyeefnoee

ea asih1oires .t.Scrll m sioIpedtqe o n sceerriare C 5i.Utnrpa mfl,dttecey lnnsmaa op scayfpomeht rt rudraeheeosr eab r ya ie$na pbe teirnnntrt la eap ghrtn o ao croem ten o m iso tr1eewr,r

et tuolnmruiea.e lyicoen mtnahteamu feiseueu ot0htf hloocb t qrwxoss 0eola pyepd dsr5llalrati$n ti s T vssi

o.nyErl uioi aS Llcl :ed C